Exposure to helicobacter pylori and serum kynurenine to tryptophan ratio in patients with gastric cancer

Pteridines

Volumn 21, Issue 4, 2010, Pages 110-120

  Engin, Ayse Basak ^a   Karahalil, Bensu ^a   Karakaya, Ali Esat ^a   Engin, Atilla ^b  

^a GAZI UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

3 dioxygenase; Biopterin; Helicobacter pylori; Indoleamine 2; Kynurenine; Neopterin; Nitric oxide; Tryptophan

Indexed keywords

BIOPTERIN; CREATININE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; NITRIC OXIDE; NITRITE; TRYPTOPHAN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CREATININE URINE LEVEL; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEGRADATION; PROTEIN FUNCTION; STOMACH CANCER;

HELICOBACTER PYLORI;

EID: 79952148026     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2010.21.1.110     Document Type: Article

References (63)

1. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol (Suppl.) 1996; 215: 48-51.
2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
3. Richy F, Mégraud F. Helicobacter pylori infection as a cause of extra-digestive diseases: myth or reality? Gastroenterol Clin Biol 2003; 27: 459-466.
4. Tsang KW, Lam SK. Helicobacter pylori and extradigestive diseases. J Gastroenterol Hepatol 1999; 14: 844-850.
5. Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr 2001; 131: 2789S-2793S.
6. Israel DA, Peek RM Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol 2006; 22: 3-7.
7. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. Clin Invest 1991; 87: 894-900.
8. Keep S, Borlace G, Butler R, Brooks D. Role of immune serum in the killing of Helicobacter pylori by macrophages. Helicobacter 2010; 15: 177-183.
9. Borlace GN, Butler RN, Brooks DA. Monocyte and macrophage killing of helicobacter pylori: relationship to bacterial virulence factors. Helicobacter 2008; 13: 380-387.
10. Wang YH, Wu JJ, Lei HY. The autophagic induction in Helicobacter pylori-infected macrophage. Exp Biol Med (Maywood) 2009; 234:171-180.
11. Ramarao N, Meyer TF. Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and?uorescenceactivated cell sorting. Infect Immun 2001; 69, 2604-2611.
12. Katsurahara M, Kobayashi Y, Iwasa M, et al. Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa. Helicobacter 2009; 14: 552-558.
13. Gobert AP, David J. McGee DJ, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc Natl Acad Sci 2001; 98: 13844-13849.
14. Bussiere FIR, Chaturvedi Y, Cheng AP, et al. Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 2005; 280: 2409-2412.
15. Luzza F, Parrello T, Sebkova L, et al. Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Dig Liver Dis 2001; 33: 14-20.
16. Itoh T, Wakatsuki Y, Yoshida M, et al. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J Gastroenterol 1999; 34: 560-70.
17. + T cell responses in Helicobacter pylori-infected individuals. Clin Exp Immunol 2001; 123: 81-87.
18. Ledochowski M, Murr C, Lass-Floerl C, Fuchs D. Helicobacter pylori infection and neopterin. Pteridines 2001; 12: 126-9.
19. Müller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Däubener W. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 2009; 13:1125-1135.
20. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999; 4: 199-220.
21. Peeters M. Urea breath test: a diagnostic tool in the management of Helicobacter pylori-related gastrointestinal diseases. Acta Gastroenterol Belg 1998; 61: 332-335.
22. Engin AB, Ergun MA, Yurtcu E, Kan D, Sahin G. Effect of ionizing radiation on the pteridine metabolic pathway and evaluation of its cytotoxicity in exposed hospital staff. Mutat Res 2005; 585: 184-192.
23. Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumorinfiltrating T cells. Clin Cancer Res 2006; 12:1144-1151.
24. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71.
25. Grisham M, Jourd-Heuil D, Wink D. Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: implications in in?ammation. Am J Physiol 1999; 276: G315-G321.
26. Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol 2010; PMID: 21103997 (Epub ahead of print).
27. Akkaya N, Akkaya S, Polat Y, et al. Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 2011; 30:43-49
28. Correa P. Does Helicobacter pylori cause gastric cancer via oxidative stress? Biol Chem 2006; 387: 361-364.
29. Smoot DT, Elliott TB, Verspaget HW, et al. Influence of Helicobacter pylori on reactive oxygen- induced gastric epithelial cell injury. Carcinogenesis 2000; 21: 2091-2095.
30. Davies, G. R., Simmonds NJ, Stevens TRJ, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-185.
31. Zhang QB, Dawodu JB, Husain A, Etolhi G, Gemmell CG, Russell RI. 1997. Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci 92: 69-73.
32. Xu HR, Chaturvedi Y, Cheng FI, et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004; 64: 8521-8525
33. Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Upregulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected humangastric epithelial cells: possible role of interferon- gamma in polarized nitric oxide secretion. Helicobacter 2002; 7: 116-28.
34. Nagata K, Yu H, Nishikawa M, et al. Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J Biol Chem 1998; 273: 14071-14073.
35. Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm Res 2010; 59: 997-1003.
36. Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996; 9: 809-820.
37. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalyanaraman B, Freeman B A. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 1995; 324: 15-25.
38. Arteel GE, Briviba K, Sies H. Protection against peroxynitrite. FEBS Lett 1999; 445: 26-230.
39. Quijano C, Alvarez B, Gatti RM,Augusto O, Radi R. Pathways of peroxynitrite oxidation of thiol groups. Biochem. J. (1997) 322, 167-173
40. Rajnakova A, Goh PM, Chan ST, et al. Expression of differantial nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 1997; 18: 1841-1845.
41. Rajnakova A, Goh PM, Chan ST, Ngoi SS, Alponat A, Moochhala S. Expression of nitric oxide synthase, syslooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001; 172:177-185.
42. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 2002; 12: 311-320.
43. Zuniae G, Coliae M, Vuceljiae M. Nitrite to nitrate molar ratio is inversely proportional to oxidative cell damages and granulocytic apoptosis at the wound site following cutaneous injury in rats. Nitric Oxide 2009; 20: 264-269.
44. Lundberg JO, Weitzberg E. NO-synthase independent NO generation in mammals. Biochem Biophys Res Commun 2010; 396: 39-45
45. Nichol CA, Smith GK, Duch DS. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu Rev Biochem 1985; 54: 729-764
46. Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun 1999; 263: 681-684.
47. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 1989; 262: 861-866.
48. Kim HL, Park YS. Maintenance of cellular tetrahydrobiopterin homeostasis. BMB Rep 2010; 43: 584-592.
49. Shen RS, Alam A, Zhang YX. Inhibition of GTP cyclohydrolase I by pterins. Biochim Biophys Acta 1988; 965: 9-15.
50. Chaturvedi R, Asim M, Lewis ND, et al. LArginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori Infect Immuni 2007; 75: 4305-4315.
51. Marais A, Mendz GL, Hazell SL, Mégraud F.Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 1999; 63: 642-674.
52. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999; 55: 1015-1028.
53. Wang WW, Jenkinson CP, Griscavage JM, et al. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995; 210: 1009-1016.
54. Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc Natl Acad Sci 2001; 98: 13844-13849.
55. Wachter H, Fuchs D, Hausen A, Reibnegger G,Weiss G,Werner ER, Werner-Felmayer G. In: Neopterin, Biochemistry, Methods, Clinical Application, Walter de Gruyter, Berlin, 1992.
56. Wirleitner B, Neurauter G, Schröcksnadel K, Frick B, Fuchs D. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem. 2003; 10: 1581-91
57. Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta. 2006; 364: 82-90
58. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002; 196: 459-468.
59. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol 2003; 81: 247-265.
60. Takikawa O, Kuroiwa T, Yamazaki F, Kido R. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon- gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 1988; 263: 2041-2048.
61. Uyttenhove C, Pilotte L, Théate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3- dioxygenase. Nat Med 2003; 9:1269-1274.
62. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002; 9: 1069-1077.
63. Lopez AS, Alegre E, Diaz A, Mugueta C, Alvaro Gonzalez A. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells. Immunol Lett 2006; 106: 163-171.